ヒトサイトメガロウイルス65 kDaリンタンパク質の世界市場 2020年

• 英文タイトル：Global Human cytomegalovirus 65 kDa Phosphoprotein Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201112077 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、ヒトサイトメガロウイルス65 kDaリンタンパク質の世界市場を調査対象にし、ヒトサイトメガロウイルス65 kDaリンタンパク質の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（HB-101、CyMVectin、ASP-0113、PepVax、その他）、用途別分析（脳腫瘍、血液腫瘍、腎臓移植拒絶反応、肝移植拒絶反応、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Astellas Pharma Inc、Vakzine Projekt Management GmbH、Hookipa Biotech AG、Vical Inc、Immunomic Therapeutics Inc、VBI Vaccines Inc、Vaximm AG ・メーカー別販売量、売上、市場シェア ・ヒトサイトメガロウイルス65 kDaリンタンパク質の地域別市場分析 ・ヒトサイトメガロウイルス65 kDaリンタンパク質の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ヒトサイトメガロウイルス65 kDaリンタンパク質のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ヒトサイトメガロウイルス65 kDaリンタンパク質のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ヒトサイトメガロウイルス65 kDaリンタンパク質の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ヒトサイトメガロウイルス65 kDaリンタンパク質の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ヒトサイトメガロウイルス65 kDaリンタンパク質の種類別市場規模2015-2020：HB-101、CyMVectin、ASP-0113、PepVax、その他 ・ヒトサイトメガロウイルス65 kDaリンタンパク質の用途別市場規模2015-2020：脳腫瘍、血液腫瘍、腎臓移植拒絶反応、肝移植拒絶反応、その他 ・ヒトサイトメガロウイルス65 kDaリンタンパク質の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論

Market Overview
The global Human cytomegalovirus 65 kDa Phosphoprotein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Human cytomegalovirus 65 kDa Phosphoprotein market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Human cytomegalovirus 65 kDa Phosphoprotein market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Human cytomegalovirus 65 kDa Phosphoprotein market has been segmented into
HB-101
CyMVectin
ASP-0113
PepVax
Others

By Application, Human cytomegalovirus 65 kDa Phosphoprotein has been segmented into:
Brain Tumor
Hemotaological Tumor
Kidney Transplant Rejection
Liver Transplant Rejection
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Human cytomegalovirus 65 kDa Phosphoprotein market presented in the report. This section sheds light on the sales growth of different regional and country-level Human cytomegalovirus 65 kDa Phosphoprotein markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Human cytomegalovirus 65 kDa Phosphoprotein market.

The report offers in-depth assessment of the growth and other aspects of the Human cytomegalovirus 65 kDa Phosphoprotein market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Human cytomegalovirus 65 kDa Phosphoprotein Market Share Analysis
Human cytomegalovirus 65 kDa Phosphoprotein competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Human cytomegalovirus 65 kDa Phosphoprotein sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Human cytomegalovirus 65 kDa Phosphoprotein sales, revenue and market share for each player covered in this report.

The major players covered in Human cytomegalovirus 65 kDa Phosphoprotein are:
Astellas Pharma Inc
Vakzine Projekt Management GmbH
Hookipa Biotech AG
Vical Inc
Immunomic Therapeutics Inc
VBI Vaccines Inc
Vaximm AG

Among other players domestic and global, Human cytomegalovirus 65 kDa Phosphoprotein market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human cytomegalovirus 65 kDa Phosphoprotein product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human cytomegalovirus 65 kDa Phosphoprotein, with price, sales, revenue and global market share of Human cytomegalovirus 65 kDa Phosphoprotein in 2018 and 2019.
Chapter 3, the Human cytomegalovirus 65 kDa Phosphoprotein competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human cytomegalovirus 65 kDa Phosphoprotein breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Human cytomegalovirus 65 kDa Phosphoprotein market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Human cytomegalovirus 65 kDa Phosphoprotein sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

Table of Contents

1 Market Overview
1.1 Human cytomegalovirus 65 kDa Phosphoprotein Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 HB-101
1.2.3 CyMVectin
1.2.4 ASP-0113
1.2.5 PepVax
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Brain Tumor
1.3.3 Hemotaological Tumor
1.3.4 Kidney Transplant Rejection
1.3.5 Liver Transplant Rejection
1.3.6 Others
1.4 Overview of Global Human cytomegalovirus 65 kDa Phosphoprotein Market
1.4.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Astellas Pharma Inc
2.1.1 Astellas Pharma Inc Details
2.1.2 Astellas Pharma Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Astellas Pharma Inc SWOT Analysis
2.1.4 Astellas Pharma Inc Product and Services
2.1.5 Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Vakzine Projekt Management GmbH
2.2.1 Vakzine Projekt Management GmbH Details
2.2.2 Vakzine Projekt Management GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Vakzine Projekt Management GmbH SWOT Analysis
2.2.4 Vakzine Projekt Management GmbH Product and Services
2.2.5 Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Hookipa Biotech AG
2.3.1 Hookipa Biotech AG Details
2.3.2 Hookipa Biotech AG Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Hookipa Biotech AG SWOT Analysis
2.3.4 Hookipa Biotech AG Product and Services
2.3.5 Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Vical Inc
2.4.1 Vical Inc Details
2.4.2 Vical Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Vical Inc SWOT Analysis
2.4.4 Vical Inc Product and Services
2.4.5 Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Immunomic Therapeutics Inc
2.5.1 Immunomic Therapeutics Inc Details
2.5.2 Immunomic Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Immunomic Therapeutics Inc SWOT Analysis
2.5.4 Immunomic Therapeutics Inc Product and Services
2.5.5 Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 VBI Vaccines Inc
2.6.1 VBI Vaccines Inc Details
2.6.2 VBI Vaccines Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 VBI Vaccines Inc SWOT Analysis
2.6.4 VBI Vaccines Inc Product and Services
2.6.5 VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Vaximm AG
2.7.1 Vaximm AG Details
2.7.2 Vaximm AG Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Vaximm AG SWOT Analysis
2.7.4 Vaximm AG Product and Services
2.7.5 Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Human cytomegalovirus 65 kDa Phosphoprotein Manufacturer Market Share in 2019
3.3.2 Top 6 Human cytomegalovirus 65 kDa Phosphoprotein Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue and Market Share by Regions
4.1.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales and Market Share by Regions (2015-2020)
4.1.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Market Share by Regions (2015-2020)
4.2 North America Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
4.3 Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
4.5 South America Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue and Market Share by Country
5.1.1 North America Human cytomegalovirus 65 kDa Phosphoprotein Sales and Market Share by Country (2015-2020)
5.1.2 North America Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Market Share by Country (2015-2020)
5.2 United States Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
5.3 Canada Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
5.4 Mexico Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue and Market Share by Country
6.1.1 Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales and Market Share by Country (2015-2020)
6.1.2 Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Market Share by Country (2015-2020)
6.2 Germany Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
6.3 UK Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
6.4 France Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
6.5 Russia Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
6.6 Italy Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Market Share by Regions (2015-2020)
7.2 China Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
7.3 Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
7.4 Korea Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
7.5 India Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
7.7 Australia Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue and Market Share by Country
8.1.1 South America Human cytomegalovirus 65 kDa Phosphoprotein Sales and Market Share by Country (2015-2020)
8.1.2 South America Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Market Share by Country (2015-2020)
8.2 Brazil Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
8.3 Argentina Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
9.3 Turkey Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
9.4 Egypt Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
9.5 South Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales and Market Share by Type (2015-2020)
10.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Market Share by Type (2015-2020)
10.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Price by Type (2015-2020)
11 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Segment by Application
11.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Application (2015-2020)
11.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Application (2015-2020)
11.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Price by Application (2015-2020)
12 Market Forecast
12.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales, Revenue and Growth Rate (2021-2025)
12.2 Human cytomegalovirus 65 kDa Phosphoprotein Market Forecast by Regions (2021-2025)
12.2.1 North America Human cytomegalovirus 65 kDa Phosphoprotein Market Forecast (2021-2025)
12.2.2 Europe Human cytomegalovirus 65 kDa Phosphoprotein Market Forecast (2021-2025)
12.2.3 Asia-Pacific Human cytomegalovirus 65 kDa Phosphoprotein Market Forecast (2021-2025)
12.2.4 South America Human cytomegalovirus 65 kDa Phosphoprotein Market Forecast (2021-2025)
12.2.5 Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Market Forecast (2021-2025)
12.3 Human cytomegalovirus 65 kDa Phosphoprotein Market Forecast by Type (2021-2025)
12.3.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Type (2021-2025)
12.3.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Share Forecast by Type (2021-2025)
12.4 Human cytomegalovirus 65 kDa Phosphoprotein Market Forecast by Application (2021-2025)
12.4.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Application (2021-2025)
12.4.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Human cytomegalovirus 65 kDa Phosphoprotein by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Astellas Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 8. Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Major Business
Table 9. Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Total Revenue (USD Million) (2018-2019)
Table 10. Astellas Pharma Inc SWOT Analysis
Table 11. Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Product and Services
Table 12. Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Vakzine Projekt Management GmbH Basic Information, Manufacturing Base and Competitors
Table 14. Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Major Business
Table 15. Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Total Revenue (USD Million) (2018-2019)
Table 16. Vakzine Projekt Management GmbH SWOT Analysis
Table 17. Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Product and Services
Table 18. Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Hookipa Biotech AG Basic Information, Manufacturing Base and Competitors
Table 20. Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Major Business
Table 21. Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Total Revenue (USD Million) (2018-2019)
Table 22. Hookipa Biotech AG SWOT Analysis
Table 23. Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Product and Services
Table 24. Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Vical Inc Basic Information, Manufacturing Base and Competitors
Table 26. Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Major Business
Table 27. Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Total Revenue (USD Million) (2018-2019)
Table 28. Vical Inc SWOT Analysis
Table 29. Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Product and Services
Table 30. Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Immunomic Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 32. Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Major Business
Table 33. Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Total Revenue (USD Million) (2018-2019)
Table 34. Immunomic Therapeutics Inc SWOT Analysis
Table 35. Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Product and Services
Table 36. Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. VBI Vaccines Inc Basic Information, Manufacturing Base and Competitors
Table 38. VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Major Business
Table 39. VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Total Revenue (USD Million) (2018-2019)
Table 40. VBI Vaccines Inc SWOT Analysis
Table 41. VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Product and Services
Table 42. VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Vaximm AG Basic Information, Manufacturing Base and Competitors
Table 44. Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Major Business
Table 45. Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Total Revenue (USD Million) (2018-2019)
Table 46. Vaximm AG SWOT Analysis
Table 47. Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Product and Services
Table 48. Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Manufacturer (2018-2019) (K Pcs)
Table 50. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Regions (2015-2020) (K Pcs)
Table 52. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Regions (2015-2020)
Table 53. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Human cytomegalovirus 65 kDa Phosphoprotein Sales by Countries (2015-2020) (K Pcs)
Table 55. North America Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Countries (2015-2020)
Table 56. North America Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Countries (2015-2020)
Table 58. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales by Countries (2015-2020) (K Pcs)
Table 59. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Countries (2015-2020)
Table 60. Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales by Regions (2015-2020) (K Pcs)
Table 62. Asia-Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Human cytomegalovirus 65 kDa Phosphoprotein Sales by Countries (2015-2020) (K Pcs)
Table 65. South America Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Countries (2015-2020)
Table 66. South America Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales by Countries (2015-2020) (K Pcs)
Table 69. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Countries (2015-2020)
Table 72. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type (2015-2020) (K Pcs)
Table 73. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Share by Type (2015-2020)
Table 74. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Type (2015-2020) (USD Million)
Table 75. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Share by Type (2015-2020)
Table 76. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application (2015-2020) (K Pcs)
Table 77. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Share by Application (2015-2020)
Table 78. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Regions (2021-2025) (K Pcs)
Table 79. Global Human cytomegalovirus 65 kDa Phosphoprotein Market Share Forecast by Regions (2021-2025)
Table 80. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Type (2021-2025) (K Pcs)
Table 81. Global Human cytomegalovirus 65 kDa Phosphoprotein Market Share Forecast by Type (2021-2025)
Table 82. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Forecast by Application (2021-2025)
Table 83. Global Human cytomegalovirus 65 kDa Phosphoprotein Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Human cytomegalovirus 65 kDa Phosphoprotein Picture
Figure 2. Global Sales Market Share of Human cytomegalovirus 65 kDa Phosphoprotein by Type in 2019
Figure 3. HB-101 Picture
Figure 4. CyMVectin Picture
Figure 5. ASP-0113 Picture
Figure 6. PepVax Picture
Figure 7. Others Picture
Figure 8. Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Application in 2018
Figure 9. Brain Tumor Picture
Figure 10. Hemotaological Tumor Picture
Figure 11. Kidney Transplant Rejection Picture
Figure 12. Liver Transplant Rejection Picture
Figure 13. Others Picture
Figure 14. Global Human cytomegalovirus 65 kDa Phosphoprotein Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Manufacturer in 2019
Figure 35. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Human cytomegalovirus 65 kDa Phosphoprotein Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Human cytomegalovirus 65 kDa Phosphoprotein Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Regions (2015-2020)
Figure 42. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Regions in 2018
Figure 43. North America Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
Figure 44. Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
Figure 46. South America Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020)
Figure 48. North America Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Countries (2015-2020)
Figure 50. North America Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Countries in 2018
Figure 51. North America Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Countries in 2018
Figure 53. United States Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Countries in 2019
Figure 59. Germany Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Regions 2019
Figure 67. China Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Countries in 2019
Figure 74. South America Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Countries in 2019
Figure 75. Brazil Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global Human cytomegalovirus 65 kDa Phosphoprotein Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Human cytomegalovirus 65 kDa Phosphoprotein Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales Human cytomegalovirus 65 kDa Phosphoprotein Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales Human cytomegalovirus 65 kDa Phosphoprotein Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales Human cytomegalovirus 65 kDa Phosphoprotein Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales Human cytomegalovirus 65 kDa Phosphoprotein Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel

---